FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

3290211000001109: Burinex K modified-release tablets (LEO Pharma) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17624701000001114 Burinex K modified-release tablets (LEO Pharma) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
17624801000001117 Burinex K modified-release tablets (LEO Pharma) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Burinex K modified-release tablets (LEO Pharma) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Burinex K modified-release tablets (LEO Pharma) Is a Bumetanide+potassium 500mcg/7.7Mmol m/r tablet false Inferred relationship Existential restriction modifier
Burinex K modified-release tablets (LEO Pharma) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Burinex K modified-release tablets (LEO Pharma) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Burinex K modified-release tablets (LEO Pharma) Has excipient Stearyl alcohol false Inferred relationship Existential restriction modifier
Burinex K modified-release tablets (LEO Pharma) Has active ingredient Potassium true Inferred relationship Existential restriction modifier
Burinex K modified-release tablets (LEO Pharma) Has active ingredient Bumetanide true Inferred relationship Existential restriction modifier
Burinex K modified-release tablets (LEO Pharma) Has active ingredient Potassium chloride false Inferred relationship Existential restriction modifier
Burinex K modified-release tablets (LEO Pharma) Has active ingredient Potassium chloride false Inferred relationship Existential restriction modifier
Burinex K modified-release tablets (LEO Pharma) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Burinex K modified-release tablets (LEO Pharma) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Burinex K modified-release tablets (LEO Pharma) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Burinex K modified-release tablets (LEO Pharma) Is a Burinex K true Inferred relationship Existential restriction modifier
Burinex K modified-release tablets (LEO Pharma) Has specific active ingredient Potassium chloride true Inferred relationship Existential restriction modifier
Burinex K modified-release tablets (LEO Pharma) Has specific active ingredient Bumetanide true Inferred relationship Existential restriction modifier
Burinex K modified-release tablets (LEO Pharma) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Burinex K modified-release tablets (LEO Pharma) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Burinex K modified-release tablets (LEO Pharma) Is a Bumetanide 500microgram / Potassium chloride 573mg (potassium 7.7mmol) modified-release tablets false Inferred relationship Existential restriction modifier
Burinex K modified-release tablets (LEO Pharma) Is a Bumetanide 500microgram / Potassium chloride 573mg (potassium 7.7mmol) modified-release tablets true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Burinex K modified-release tablets (LEO Pharma) 28 tablet 2 x 14 tablets Is pack of False Burinex K modified-release tablets (LEO Pharma) Inferred relationship Existential restriction modifier
Burinex K modified-release tablets (LEO Pharma) 28 tablet 2 x 14 tablets Has AMP True Burinex K modified-release tablets (LEO Pharma) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start